Genomic Landscapes and Clonality of De Novo AML
Authors:
- John BrewinJBJohn Brewin
- Gillian HorneGHGillian Horne
- Timothy ChevassutTCTimothy Chevassut
- 10 October 2013
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 369 (15) , 1472-1473
Abstract
To the Editor: In reviewing the analysis of the genomic and epigenomic landscapes of de novo acute myeloid leukemia (AML) by the Cancer Genome Atlas Research Network (May 30 issue),1 we were struck by an apparent discrepancy in the reported clonal architecture of the AML samples as compared with that reported by Ding et al.2 (an average of one to two distinct clones identified vs. four or more). This discrepancy may reflect the limited depth of the sequencing analysis performed in the more recent study.1 More important, the authors do not reveal which mutations occur in the founding clone, as . . .Keywords
This publication has 4 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemiaHaematologica, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012